“The DEA would come in and destroy you”: a qualitative study of fear and unintended consequences among opioid prescribers in WV

Abstract

Background West Virginia has one of the highest rates of opioid overdose related deaths and is known as the epicenter of the opioid crisis in the United States. In an effort to reduce opioid-related harms, SB 273 was signed in 2018, and aimed to restrict opioid prescribing in West Virginia. SB 273 was enacted during a time when physician arrests and convictions had been increasing for years and were becoming more prevalent and more publicized. This study aims to better understand the impact of the legislation on patients and providers. Methods Twenty semi-structured interviews were conducted with opioid-prescribing primary care physicians and specialists practicing throughout West Virginia. Results Four themes emerged, 1. Fear of disciplinary action, 2. Exacerbation of opioid prescribing fear due to restrictive legislation, 3. Care shifts and treatment gaps, and 4. Conversion to illicit substances. The clinicians recognized the harms of inappropriate prescribing and how this could affect their patients. Decreases in opioid prescribing were already occurring prior to the law implementation. Disciplinary actions against opioid prescribers resulted in prescriber fear, which was then exacerbated by SB 273 and contributed to shifts in care that led to forced tapering and opioid under-prescribing. Providers felt that taking on patients who legitimately required opioids could jeopardize their career. Conclusion A holistic and patient-centered approach should be taken by legislative and disciplinary bodies to ensure patients are not abandoned when disciplinary actions are taken against prescribers or new legislation is passed.

Management of pain in the cancer patient

“…These limitations have occurred in the form of opioid shortages, ( 50 ) decline in the amount and dosing of opioids to patients with advanced cancers, ( 51 – 53 ) and perceived barriers by cancer patients to receive opioids for their pain ( 54 ). The physician's hesitancy to prescribe controlled substances may stem from perceived and real risks associated with regulatory and legal scrutiny ( 55 ). Furthermore, the APS declared bankruptcy from litigation costs relating to the allegations of its role in the crisis and closed its operations in 2019 ( 56 ).…”

Nurse Practitioner Perspectives of Setting-Specific Opioid Prescribing Guidelines in Ontario: A Qualitative Study

“…Although the opioid epidemic has led to many deaths, it has also caused fear among health care providers. Research shows that many providers under-prescribe opioids due to fears of addiction and penalties for overprescribing (Dzierzanowski & Kozlowski, 2020;Sedney et al, 2022). Under-prescribing opioids often leads to undertreated pain, a burden that can be prevented.…”

Using an individualized pain management plan for African American adults with sickle cell disease

“…The traditional management of pain consisted of using one long-acting opioid with a short-acting opioid for breakthrough pain relief to eliminate pain. At the onset of the nationally declared opioid epidemic and published CDC recommendations for opioid prescribing guidelines, health care providers were afraid and confused about potential sanctions (Edwards, 2018; Sedney et al, 2022). The pendulum shift caused health care providers to fear lawsuits, incarceration, suspension of licensure, or termination.…”